• FirefoxInstall the new Firefox »
  •  Dow Down0.58% Nasdaq Down0.26%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    1.05 Up 0.07(7.16%) 4:00PM EST
    |After Hours : 1.05 0.00 (0.00%) 4:24PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 2,222   1,089   1,849  
    Cost of Revenue -   -   -  
    Gross Profit 2,222   1,089   1,849  
    Operating Expenses
    Research Development89,682  82,574  91,828  
    Selling General and Administrative14,911  26,930  24,116  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (102,371) (108,415) (114,095)
    Income from Continuing Operations
    Total Other Income/Expenses Net216  318  408  
    Earnings Before Interest And Taxes(102,155)(108,097)(113,687)
    Interest Expense1,971  2,114  2,528  
    Income Before Tax(104,126)(110,211)(116,215)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(104,126)(110,211)(116,215)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (104,126) (110,211) (116,215)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (104,126) (110,211) (116,215)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.